Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
Recruiting
Observational Study
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 69
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- German Diabetes Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of diabetes mellitus according to ADA criteria
* Age 18-69
* Diabetes duration since diagnosis \< 12 months
* Control cohort: proven normal glucose tolerance according to ADA criteria
Exclusion Criteria:
* Diabetes mellitus category 3 B-H (ADA criteria)
* …
Contacts